1. Home
  2. |Insights
  3. |SBA Proposes Sweeping Expansion of the Mentor-Protégé Program

SBA Proposes Sweeping Expansion of the Mentor-Protégé Program

Client Alert | 1 min read | 02.13.15

On February 5, 2015, the SBA issued a proposed rule implementing portions of FY 2013 NDAA regarding the establishment of a universal mentor-protégé program available to all small businesses (instead of just certain SBA-approved 8(a) contractors under the current program) that would allow, among other benefits, approved mentor-protégés to compete as a joint venture for set-aside awards for which the protégé would otherwise be eligible. The SBA is seeking comments (due by April 6, 2015) on a number of aspects of this proposed rule, including whether the SBA should require all joint ventures in this program to be formed as separate legal entities and whether there should be a maximum of two mentors per protégé.

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...